The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hospitalization for patients in the United States (US) and European Union (EU) treated with inotuzumab ozogamicin (InO) vs standard of care (SOC) for relapsed/refractory acute lymphoblastic leukemia (R/R ALL) in a global phase 3 trial.
 
Yun Su
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Ilse van Oostrum
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Merck (Inst); Pfizer (Inst)
Research Funding - Amgen (Inst); Celgene (Inst); Merck (Inst); Pfizer (Inst)
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Verna Welch
Employment - Pfizer; Teva
Stock and Other Ownership Interests - Pfizer; Teva
 
Fausto Rodriguez Loberiza
Employment - Pfizer
Stock and Other Ownership Interests - Novartis; Pfizer